Tenax Therapeutics Inc (NASDAQ:TENX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TENX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TENX

  • Market Cap$14.510m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS88032L2097

Company Profile

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.Tenax Therapeutics Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products for critical care patients and its products include Levosimendan and Oxycyte.

Latest TENX news

Currently there for this company. Visit our news hub for other news .